Annual Total Liabilities
$5.72 M
-$125.00 K-2.14%
December 1, 2023
Summary
- As of February 7, 2025, NBY annual total liabilities is $5.72 million, with the most recent change of -$125.00 thousand (-2.14%) on December 1, 2023.
- During the last 3 years, NBY annual total liabilities has risen by +$2.80 million (+95.89%).
- NBY annual total liabilities is now -58.57% below its all-time high of $13.81 million, reached on December 31, 2021.
Performance
NBY Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Total Liabilities
$2.81 M
-$1.74 M-38.24%
September 1, 2024
Summary
- As of February 7, 2025, NBY quarterly total liabilities is $2.81 million, with the most recent change of -$1.74 million (-38.24%) on September 1, 2024.
- Over the past year, NBY quarterly total liabilities has dropped by -$3.01 million (-51.76%).
- NBY quarterly total liabilities is now -79.68% below its all-time high of $13.81 million, reached on December 31, 2021.
Performance
NBY Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Total Liabilities Formula
Total Liabilities = Current Liabilities + Long-Term Liabilities
NBY Total Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -2.1% | -51.8% |
| 3 y3 years | +95.9% | -62.3% |
| 5 y5 years | +29.8% | -62.3% |
NBY Total Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -58.6% | at low | -79.7% | at low |
| 5 y | 5-year | -58.6% | +95.9% | -79.7% | +17.2% |
| alltime | all time | -58.6% | +1745.2% | -79.7% | +804.8% |
NovaBay Pharmaceuticals Total Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $2.81 M(-38.2%) |
| Jun 2024 | - | $4.54 M(-12.6%) |
| Mar 2024 | - | $5.20 M(-9.1%) |
| Dec 2023 | $5.72 M(-2.1%) | $5.72 M(-1.6%) |
| Sep 2023 | - | $5.82 M(-21.9%) |
| Jun 2023 | - | $7.45 M(+25.4%) |
| Mar 2023 | - | $5.93 M(+1.5%) |
| Dec 2022 | $5.84 M(-57.7%) | $5.84 M(-32.0%) |
| Sep 2022 | - | $8.59 M(+48.2%) |
| Jun 2022 | - | $5.80 M(-17.7%) |
| Mar 2022 | - | $7.05 M(-49.0%) |
| Dec 2021 | $13.81 M(+372.8%) | $13.81 M(+380.2%) |
| Sep 2021 | - | $2.88 M(+20.1%) |
| Jun 2021 | - | $2.39 M(-22.5%) |
| Mar 2021 | - | $3.09 M(+5.8%) |
| Dec 2020 | $2.92 M(-71.5%) | $2.92 M(-8.8%) |
| Sep 2020 | - | $3.20 M(-74.0%) |
| Jun 2020 | - | $12.29 M(+25.1%) |
| Mar 2020 | - | $9.82 M(-4.1%) |
| Dec 2019 | $10.25 M(+132.5%) | $10.25 M(-12.3%) |
| Sep 2019 | - | $11.68 M(+42.4%) |
| Jun 2019 | - | $8.20 M(-4.5%) |
| Mar 2019 | - | $8.59 M(+94.9%) |
| Dec 2018 | $4.41 M(-41.1%) | $4.41 M(+2.3%) |
| Sep 2018 | - | $4.31 M(+0.7%) |
| Jun 2018 | - | $4.28 M(-13.7%) |
| Mar 2018 | - | $4.95 M(-33.8%) |
| Dec 2017 | $7.49 M(-9.6%) | $7.49 M(-18.9%) |
| Sep 2017 | - | $9.22 M(+4.1%) |
| Jun 2017 | - | $8.86 M(+6.4%) |
| Mar 2017 | - | $8.33 M(+0.6%) |
| Dec 2016 | $8.28 M(-18.6%) | $8.28 M(-1.7%) |
| Sep 2016 | - | $8.42 M(-11.1%) |
| Jun 2016 | - | $9.47 M(-22.6%) |
| Mar 2016 | - | $12.23 M(+20.2%) |
| Dec 2015 | $10.18 M | $10.18 M(+57.4%) |
| Sep 2015 | - | $6.46 M(+22.6%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2015 | - | $5.27 M(-12.3%) |
| Mar 2015 | - | $6.01 M(+5.6%) |
| Dec 2014 | $5.69 M(-20.3%) | $5.69 M(+6.3%) |
| Sep 2014 | - | $5.35 M(+24.7%) |
| Jun 2014 | - | $4.29 M(-19.7%) |
| Mar 2014 | - | $5.35 M(-25.0%) |
| Dec 2013 | $7.13 M(+37.6%) | $7.13 M(+4.6%) |
| Sep 2013 | - | $6.82 M(+21.5%) |
| Jun 2013 | - | $5.62 M(+10.6%) |
| Mar 2013 | - | $5.08 M(-2.1%) |
| Dec 2012 | $5.19 M(-21.6%) | $5.19 M(-16.7%) |
| Sep 2012 | - | $6.23 M(-3.6%) |
| Jun 2012 | - | $6.46 M(-3.2%) |
| Mar 2012 | - | $6.67 M(+0.8%) |
| Dec 2011 | $6.62 M(+31.7%) | $6.62 M(+23.5%) |
| Sep 2011 | - | $5.36 M(-0.8%) |
| Jun 2011 | - | $5.40 M(-5.7%) |
| Mar 2011 | - | $5.72 M(+13.9%) |
| Dec 2010 | $5.03 M(+20.3%) | $5.03 M(+60.3%) |
| Sep 2010 | - | $3.14 M(+33.1%) |
| Jun 2010 | - | $2.36 M(-40.8%) |
| Mar 2010 | - | $3.98 M(-4.7%) |
| Dec 2009 | $4.18 M(-36.9%) | $4.18 M(-26.1%) |
| Sep 2009 | - | $5.65 M(+1.5%) |
| Jun 2009 | - | $5.57 M(-25.3%) |
| Mar 2009 | - | $7.46 M(+12.6%) |
| Dec 2008 | $6.62 M(-31.0%) | $6.62 M(-24.7%) |
| Sep 2008 | - | $8.79 M(-4.9%) |
| Jun 2008 | - | $9.25 M(-10.6%) |
| Mar 2008 | - | $10.35 M(+7.7%) |
| Dec 2007 | $9.60 M(-4.5%) | $9.60 M(-10.7%) |
| Sep 2007 | - | $10.75 M(+4.9%) |
| Jun 2007 | - | $10.24 M(-5.1%) |
| Mar 2007 | - | $10.80 M(+7.4%) |
| Dec 2006 | $10.05 M(+3142.9%) | $10.05 M(+3142.9%) |
| Dec 2005 | $310.00 K(-39.6%) | $310.00 K |
| Dec 2003 | $513.00 K | - |
FAQ
- What is NovaBay Pharmaceuticals annual total liabilities?
- What is the all time high annual total liabilities for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals annual total liabilities year-on-year change?
- What is NovaBay Pharmaceuticals quarterly total liabilities?
- What is the all time high quarterly total liabilities for NovaBay Pharmaceuticals?
- What is NovaBay Pharmaceuticals quarterly total liabilities year-on-year change?
What is NovaBay Pharmaceuticals annual total liabilities?
The current annual total liabilities of NBY is $5.72 M
What is the all time high annual total liabilities for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high annual total liabilities is $13.81 M
What is NovaBay Pharmaceuticals annual total liabilities year-on-year change?
Over the past year, NBY annual total liabilities has changed by -$125.00 K (-2.14%)
What is NovaBay Pharmaceuticals quarterly total liabilities?
The current quarterly total liabilities of NBY is $2.81 M
What is the all time high quarterly total liabilities for NovaBay Pharmaceuticals?
NovaBay Pharmaceuticals all-time high quarterly total liabilities is $13.81 M
What is NovaBay Pharmaceuticals quarterly total liabilities year-on-year change?
Over the past year, NBY quarterly total liabilities has changed by -$3.01 M (-51.76%)